Log in

NASDAQ:NVCNNeovasc Stock Price, Forecast & News

$2.41
+0.03 (+1.26 %)
(As of 07/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.34
Now: $2.41
$2.47
50-Day Range
$2.31
MA: $2.68
$3.34
52-Week Range
$1.24
Now: $2.41
$8.65
Volume228,500 shs
Average Volume348,781 shs
Market Capitalization$26.83 million
P/E RatioN/A
Dividend YieldN/A
Beta2.76
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets cardiovascular devices worldwide. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company also provides Peripatch tissue products. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.
Read More
Neovasc logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.26 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NVCN
CUSIPN/A
Phone604-248-4138

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.09 million
Book Value($1.46) per share

Profitability

Net Income$-35,130,000.00
Net Margins-1,501.37%

Miscellaneous

Employees98
Market Cap$26.83 million
Next Earnings Date8/5/2020 (Estimated)
OptionableNot Optionable

Receive NVCN News and Ratings via Email

Sign-up to receive the latest news and ratings for NVCN and its competitors with MarketBeat's FREE daily newsletter.

Neovasc (NASDAQ:NVCN) Frequently Asked Questions

How has Neovasc's stock been impacted by COVID-19 (Coronavirus)?

Neovasc's stock was trading at $2.21 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, NVCN shares have increased by 9.0% and is now trading at $2.41. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Neovasc?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neovasc in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Neovasc.

When is Neovasc's next earnings date?

Neovasc is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Neovasc.

How were Neovasc's earnings last quarter?

Neovasc Inc (NASDAQ:NVCN) posted its earnings results on Thursday, May, 7th. The medical equipment provider reported ($0.38) EPS for the quarter, beating the consensus estimate of ($0.55) by $0.17. The medical equipment provider had revenue of $0.53 million for the quarter, compared to the consensus estimate of $0.60 million. View Neovasc's earnings history.

When did Neovasc's stock split? How did Neovasc's stock split work?

Neovasc's stock reverse split on Friday, September 21st 2018. The 1-100 reverse split was announced on Tuesday, September 11th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 20th 2018. An investor that had 100 shares of Neovasc stock prior to the reverse split would have 1 shares after the split.

What guidance has Neovasc issued on next quarter's earnings?

Neovasc issued an update on its second quarter 2020 IntraDay earnings guidance on Monday, July, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $295K - 295K.

What price target have analysts set for NVCN?

3 brokers have issued 12 month price objectives for Neovasc's shares. Their forecasts range from $3.00 to $15.00. On average, they anticipate Neovasc's share price to reach $7.67 in the next twelve months. This suggests a possible upside of 218.1% from the stock's current price. View analysts' price targets for Neovasc.

Has Neovasc been receiving favorable news coverage?

Media coverage about NVCN stock has trended negative on Wednesday, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Neovasc earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned headlines about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news about Neovasc.

Are investors shorting Neovasc?

Neovasc saw a drop in short interest in the month of June. As of June 15th, there was short interest totaling 210,600 shares, a drop of 14.1% from the May 31st total of 245,300 shares. Based on an average daily trading volume, of 216,500 shares, the short-interest ratio is currently 1.0 days. Approximately 1.9% of the company's shares are short sold. View Neovasc's Current Options Chain.

Who are some of Neovasc's key competitors?

What other stocks do shareholders of Neovasc own?

Who are Neovasc's key executives?

Neovasc's management team includes the following people:
  • Mr. Fredericus A. Colen, Pres & CEO (Age 66)
  • Mr. Christopher Clark B.A., C.A., BA (Honours), PgD, CA, CFO & Corp. Sec. (Age 47)

What is Neovasc's stock symbol?

Neovasc trades on the NASDAQ under the ticker symbol "NVCN."

How do I buy shares of Neovasc?

Shares of NVCN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Neovasc's stock price today?

One share of NVCN stock can currently be purchased for approximately $2.41.

How big of a company is Neovasc?

Neovasc has a market capitalization of $26.83 million and generates $2.09 million in revenue each year. The medical equipment provider earns $-35,130,000.00 in net income (profit) each year or ($5.05) on an earnings per share basis. Neovasc employs 98 workers across the globe.

What is Neovasc's official website?

The official website for Neovasc is www.neovasc.com.

How can I contact Neovasc?

Neovasc's mailing address is Suite 5138 - 13562 Maycrest Way, RICHMOND A1, V6V 2J7. The medical equipment provider can be reached via phone at 604-248-4138 or via email at [email protected]

This page was last updated on 7/8/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.